Share Mivara as a waitlist, not a treatment promise.
Use this page when someone asks what Mivara is. The share language is built for launch updates only while legal, clinical, pharmacy, privacy, payment, and advertising approvals are completed.
Use named warm recipients, owned profiles, inbound conversations, or manually vetted partner contacts only.
2
Rule 2
No scraped lists, purchased lists, uploaded custom audiences, cold bulk email, boosted posts, paid ads, or lead-form ads.
3
Rule 3
No PHI, medical history, medication questions, insurance IDs, photos, payment data, prescriptions, labs, diagnosis, or urgent advice.
4
Rule 4
Every public post or outbound message must keep the offer as waitlist-only launch updates.
Compliance preview: Mivara is configured for waitlist and operational readiness only. No prescriptions, diagnoses, medical advice, or paid treatment are available until legal, clinical, pharmacy, payment, and privacy approvals are complete.
Source-tagged waitlist links
Use the closest link for the channel so demand can be attributed without collecting sensitive details.
Founding access landing page
ready after deploy
Consumer demand capture from owned profiles and direct shares.
No payment, medical intake, prescriptions, outcomes, or private health details.
These drafts avoid specific medication claims, outcome claims, and fake proof.
Friend referral
I joined Mivara’s waitlist for updates about a future licensed clinician-reviewed metabolic health access pathway. It’s waitlist-only right now and does not request medical details: https://joinmivara.com/founding-access?utm_source=referral&utm_medium=share&utm_campaign=founding_access
Partner referral
Mivara is collecting non-clinical partner interest for a future compliance-first metabolic health access platform. No patient data, contracts, or paid services requested yet: https://joinmivara.com/partners?utm_source=referral&utm_medium=share&utm_campaign=partner_pilot_pipeline
Email share
Thought this might be relevant: Mivara is opening waitlist-only updates for a future clinician-reviewed metabolic health access pathway after approvals. https://joinmivara.com/founding-access?utm_source=email_share&utm_medium=email&utm_campaign=founding_access
Do not cross these lines
These controls protect the brand, vendor approvals, future ad accounts, and payment review.
Use named warm recipients, owned profiles, inbound conversations, or manually vetted partner contacts only.
No scraped lists, purchased lists, uploaded custom audiences, cold bulk email, boosted posts, paid ads, or lead-form ads.
No PHI, medical history, medication questions, insurance IDs, photos, payment data, prescriptions, labs, diagnosis, or urgent advice.
Every public post or outbound message must keep the offer as waitlist-only launch updates.
Stop and re-review if a message mentions drug names, dosing, guaranteed outcomes, before/after results, same-day prescription access, or compounded-drug FDA approval.